MLAB
BEARISH
$97.85
Live
Mesa Laboratories, Inc. · NASDAQ
Target $104.5
(+6.8%)
$55.45
52W Range
$131.2
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 14, 2026
Market cap
$540.6M
P/E
150.54
ROE
2.2%
Profit margin
1.5%
Debt/Equity
0.91
Dividend yield
0.65%
AI Analysis
AI-powered fundamental assessment
Confidence
85%
MLAB exhibits a stable financial health profile with a Piotroski F-Score of 6/9, but it is fundamentally disconnected from its valuation. The stock trades at a massive premium to its Graham Number ($22.23) and Intrinsic Value ($4.55), with a trailing P/E of 150.54. While the forward P/E of 18.15 suggests an expected earnings recovery, the current dividend payout ratio of 98.46% is unsustainable. Long-term price performance is severely negative, indicating a persistent lack of value creation over a 5-year horizon.
Key Strengths
Stable financial health (Piotroski F-Score 6/9)
Strong Gross Margin of 62.40%
Healthy liquidity with a Current Ratio of 1.94
Positive short-term price momentum (6M +43.8%)
Manageable Debt/Equity ratio of 0.91
Key Risks
Extreme valuation gap between current price ($97.85) and Graham Number ($22.23)
Unsustainable dividend payout ratio of 98.46%
Very low Return on Equity (ROE) of 2.18%
Sluggish revenue growth (YoY 3.60%)
Highly volatile earnings history with significant quarterly misses
AI Fair Value Estimate
Based on comprehensive analysis
$32.5
-66.8% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
32
Weak
15
45
20
70
10
AI Verdict
Overvalued with unstable yield
Key drivers: Valuation disconnect, Dividend sustainability, Poor long-term price performance
Confidence
90%
Value
15/100
Ref P/E, PEG, Graham Number
Positives
- Forward P/E is reasonable at 18.15
Watchpoints
- Trailing P/E of 150.54
- Price is ~4.4x the Graham Number
- Price is ~21x the Intrinsic Value
Future
45/100
Ref Growth rates
Positives
- Expected earnings growth implied by Forward P/E
Watchpoints
- Low current revenue growth (3.6%)
- Low ROE suggests poor capital efficiency
Past
20/100
Ref Historical trends
Positives
- Recent 6-month recovery
Watchpoints
- 5-year price change of -61%
- Erratic earnings surprises
Health
70/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score 6/9
- Current Ratio 1.94
- Quick Ratio 1.30
Watchpoints
- Low profit margins (1.51%)
Dividend
10/100
Ref Yield, Payout
Positives
- Consistent payment
Watchpoints
- Payout ratio of 98.46% leaves no room for error or growth
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$97.85
Analyst Target
$104.5
Upside/Downside
+6.8%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for MLAB and closest competitors.
Updated 2026-04-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
Primary
|
-61.0% | -39.5% | -13.6% | +43.8% | +25.5% | +3.8% |
|
AMBQ
Ambiq Micro, Inc.
Peer
|
-34.2% | -34.2% | -34.2% | -26.4% | -13.5% | -10.7% |
|
GLOO
Gloo Holdings, Inc.
Peer
|
-22.2% | -22.2% | -22.2% | -22.2% | +3.5% | +10.7% |
|
INDI
indie Semiconductor, Inc.
Peer
|
-71.9% | -68.6% | +53.2% | -29.9% | +12.4% | -7.0% |
|
IMXI
International Money Express, Inc.
Peer
|
+6.5% | -37.6% | +32.9% | +9.1% | +0.2% | +0.1% |
MLA
Mesa Laboratories, Inc.
Primary
5Y
-61.0%
3Y
-39.5%
1Y
-13.6%
6M
+43.8%
1M
+25.5%
1W
+3.8%
AMB
Ambiq Micro, Inc.
Peer
5Y
-34.2%
3Y
-34.2%
1Y
-34.2%
6M
-26.4%
1M
-13.5%
1W
-10.7%
GLO
Gloo Holdings, Inc.
Peer
5Y
-22.2%
3Y
-22.2%
1Y
-22.2%
6M
-22.2%
1M
+3.5%
1W
+10.7%
IND
indie Semiconductor, Inc.
Peer
5Y
-71.9%
3Y
-68.6%
1Y
+53.2%
6M
-29.9%
1M
+12.4%
1W
-7.0%
IMX
International Money Express, Inc.
Peer
5Y
+6.5%
3Y
-37.6%
1Y
+32.9%
6M
+9.1%
1M
+0.2%
1W
+0.1%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
150.54
Forward P/E
18.15
PEG Ratio
N/A
P/B Ratio
2.9
P/S Ratio
2.18
EV/Revenue
2.75
EV/EBITDA
16.1
Market Cap
$540.6M
Profitability
Profit margins and return metrics
Profit Margin
1.51%
Operating Margin
12.25%
Gross Margin
62.41%
ROE
2.18%
ROA
2.47%
Growth
Revenue and earnings growth rates
Revenue Growth
+3.6%
Earnings Growth
N/A
Q/Q Revenue Growth
+3.64%
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.91
Moderate
Current Ratio
1.94
Good
Quick Ratio
1.3
Good
Cash/Share
$5.51
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$0.1B
Gross Margin
64.2%
Op. Margin
12.2%
Net Margin
5.6%
Total Assets
$0.4B
Liabilities
$0.2B
Equity
$0.2B
Debt/Equity
1.33x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
96%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-05-28
$N/A
2026-02-03
$1.76
+19.9% surprise
2025-11-06
$2.11
+35.1% surprise
2025-08-05
$1.88
-12.9% surprise
Technology Sector Comparison
Comparing MLAB against 305 companies in the Technology sector
(25 bullish, 105 neutral, 175 bearish)
P/E Ratio
150.54
This Stock
vs
98.13
Sector Avg
+53.4%
(Expensive)
Return on Equity (ROE)
2.18%
This Stock
vs
-22.69%
Sector Avg
-109.6%
(Below Avg)
Profit Margin
1.51%
This Stock
vs
-10.13%
Sector Avg
-114.9%
(Weaker)
Debt to Equity
0.91
This Stock
vs
0.72
Sector Avg
+25.9%
(Higher)
Revenue Growth
3.6%
This Stock
vs
8051.37%
Sector Avg
-100.0%
(Slower)
Current Ratio
1.94
This Stock
vs
3.72
Sector Avg
-47.8%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
MLAB
Mesa Laboratories, Inc.
|
BEARISH | $540.6M | 150.54 | 2.2% | 1.5% | $97.85 | |
|
AMBQ
Ambiq Micro, Inc.
|
BEARISH | $531.38M | - | -29.4% | -50.3% | $25.36 | Compare |
|
GLOO
Gloo Holdings, Inc.
|
BEARISH | $502.94M | - | -% | -225.8% | $6.22 | Compare |
|
INDI
indie Semiconductor, Inc.
|
BEARISH | $602.79M | - | -36.3% | -65.8% | $2.91 | Compare |
|
IMXI
International Money Express, Inc.
|
BEARISH | $476.76M | 14.65 | 22.1% | 5.4% | $15.82 | Compare |
MLAB
Mesa Laboratories, Inc.
BEARISH
Mkt Cap
$541M
P/E
150.5
ROE
2.2%
Price
$97.85
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | LADIWALA SHIRAZ SHABANALI | Director | Purchase | 3,500 | $252,805 |
| 2026-03-10 | TRIPENY R TONY | Director | Purchase | 1,315 | $99,940 |
| 2026-03-10 | CAPONE MARK CHRISTOPHER | Director | Purchase | 1,301 | $99,331 |
| 2025-12-02 | SULLIVAN JOHN JAMES | Director | Gift | 2,000 | - |
| 2025-10-27 | OWENS GARY M | Chief Executive Officer | Stock Award | 11,558 | - |
LADIWALA SHIRAZ SHABANALI
Director
2026-03-10
3,500 shares
·
$252,805
TRIPENY R TONY
Director
2026-03-10
1,315 shares
·
$99,940
CAPONE MARK CHRISTOPHER
Director
2026-03-10
1,301 shares
·
$99,331
SULLIVAN JOHN JAMES
Director
2025-12-02
2,000 shares
OWENS GARY M
Chief Executive Officer
2025-10-27
11,558 shares
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
NONE
2 analysts
Wells Fargo
2026-02-04
Equal-Weight
Equal-Weight
Wells Fargo
2025-12-15
Equal-Weight
Equal-Weight
Past News Coverage
Recent headlines mentioning MLAB from our newsroom.
Newest → oldest
No matching news yet.